Sign in
4

Changes in Ownership

NEKTAR THERAPEUTICS Filed Acc 0001209191-17-056534

President & CEO sold 83,333 shares at $24.20 ($2,016,659)

  • President & CEO acquired 83,333 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I In the form
ROBIN HOWARD W President & CEO 2017-10-09 Option exercise +83,333 $11.34 $944,996 235,837 D
ROBIN HOWARD W President & CEO 2017-10-09 Sale −83,333 $24.20 $2,016,659 152,504 D
Derivatives
ROBIN HOWARD W President & CEO 2017-10-09 Option exercise · Stock Option −83,333 250,000 D
Open-market sales · 83,333 sh · avg $24.20 · $2,016,659
Loading xslF345X03/doc4.xml…